Debt-to-equity of Galera Therapeutics, Inc. from 30 Jun 2020 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Galera Therapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2020 to 30 Sep 2025.
  • Galera Therapeutics, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was -103%, a 9.1% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Galera Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -103% +10% +9.1% 30 Sep 2025
Q2 2025 -104% +15% +13% 30 Jun 2025
Q1 2025 -106% +20% +16% 31 Mar 2025
Q4 2024 -109% +28% +20% 31 Dec 2024
Q3 2024 -113% +29% +21% 30 Sep 2024
Q2 2024 -119% +30% +20% 30 Jun 2024
Q1 2024 -126% +30% +19% 31 Mar 2024
Q4 2023 -137% +26% +16% 31 Dec 2023
Q3 2023 -142% +44% +24% 30 Sep 2023
Q2 2023 -148% +75% +34% 30 Jun 2023
Q1 2023 -156% +131% +46% 31 Mar 2023
Q4 2022 -163% +205% +56% 31 Dec 2022
Q3 2022 -186% +418% +69% 30 Sep 2022
Q2 2022 -223% +6849% +97% 30 Jun 2022
Q1 2022 -287% -794% -157% 31 Mar 2022
Q4 2021 -368% -612% -251% 31 Dec 2021
Q3 2021 -604% -753% -506% 30 Sep 2021
Q2 2021 -7072% -8483% -601% 30 Jun 2021
Q1 2021 507% 31 Mar 2021
Q4 2020 244% 31 Dec 2020
Q3 2020 149% 30 Sep 2020
Q2 2020 1410% 30 Jun 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.